| Summary of Segment Loss Including Segment Expenses |
The table below is a summary of the segment loss, including significant segment expenses (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
|
Nine months ended September 30, |
|
|
|
2026 |
|
|
2025 (1) |
|
|
2026 |
|
|
2025 (1) |
|
|
|
(in thousands) |
(in thousands) |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research, development, and laboratory |
|
$ |
11,819 |
|
|
$ |
10,483 |
|
|
$ |
32,468 |
|
|
$ |
31,535 |
|
Facility costs |
|
|
11,546 |
|
|
|
11,080 |
|
|
|
32,391 |
|
|
|
33,652 |
|
Support functions |
|
|
6,880 |
|
|
|
6,637 |
|
|
|
21,058 |
|
|
|
21,707 |
|
Stock-based compensation |
|
|
5,325 |
|
|
|
5,475 |
|
|
|
16,329 |
|
|
|
19,126 |
|
Technical operations and manufacturing |
|
|
6,842 |
|
|
|
4,667 |
|
|
|
16,475 |
|
|
|
16,615 |
|
Other(2) |
|
|
2,461 |
|
|
|
2,049 |
|
|
|
7,840 |
|
|
|
6,531 |
|
Research and development related success payments and contingent consideration |
|
|
(63,379 |
) |
|
|
3,124 |
|
|
|
(31,033 |
) |
|
|
15,343 |
|
Impairment of long-lived assets |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
44,611 |
|
Total operating expenses |
|
|
(18,506 |
) |
|
|
43,515 |
|
|
|
95,528 |
|
|
|
189,120 |
|
Income (loss) from operations |
|
|
18,506 |
|
|
|
(43,515 |
) |
|
|
(95,528 |
) |
|
|
(189,120 |
) |
Interest income, net |
|
|
1,219 |
|
|
|
1,003 |
|
|
|
3,299 |
|
|
|
2,572 |
|
Other income, net |
|
|
676 |
|
|
|
360 |
|
|
|
1,785 |
|
|
|
1,207 |
|
Net income (loss) |
|
$ |
20,401 |
|
|
$ |
(42,152 |
) |
|
$ |
(90,444 |
) |
|
$ |
(185,341 |
) |
(1) Certain amounts for the three and nine months ended September 30, 2025 have been reclassified to conform to the presentation as of the three and nine months ended September 30, 2026. (2) Other includes licensing costs, consulting fees, insurance, and business taxes for the three and nine months ended September 30, 2026 and 2025.
|